Skip to main content
Signal8

INTELLIGENT BIO SOLUTIONS INC. (INBS)

Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Intelligent Bio Solutions Inc. logo

Intelligent Bio Solutions Inc.

NASDAQ:INBSHealthcare
-3.83%$1.76
AH$1.76+0.00%vs close
Mkt Cap$5.84M
Float3.08M
O/S3.32M
Vol
$ Vol
RVOL
Inst Own5.5%
SI3.0%
Earnings
Dilution
Financials Summary
Revenue$4.22M
Net Income-$12.43M
Total Assets$11.94M
Free Cash Flow-$12.05M
Debt & Equity
Debt 25%
Equity 75%
Total Debt$1.82M
Total Equity$5.51M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:10

Nasdaq bars a compliance period at 1:250

  1. 1:10Reverse split
    Dec 16, 202510 shares → 1
  2. 1:12Reverse split
    Jan 29, 202412 shares → 1
  3. 1:20Reverse split
    Feb 10, 202320 shares → 1
Balance Sheet Details
Assets$11.94M
Liabilities$6.65M
Accounts Receivable$848K
Accounts Payable$712K
Inventory$419K
PP&E (Net)$2.05M
Goodwill$0
Intangible Assets$2.8M
Income Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$4.22M$3.05M$3.11M$1.26M$0$1.98M$189K$0$0$0
YoY Growth38.1%-1.9%147.6%--949.3%----
Cost of Revenue$2.17M$1.81M$1.69M$930K$0$0$0$0$0$0
Gross Profit$2.05M$1.25M$1.43M$327K$0$1.98M$189K$0$0$0
Gross Margin48.6%40.8%45.8%26.0%-100.0%100.0%---
Research and Development$3.37M$2.4M$1.67M$507K$3.85M$3.84M$588K$3.18M$2.53M$0
Selling, General, and Administrative$10.5M$8.88M$9.26M$8.03M$4.92M$3.36M$2.2M$3.55M$2.08M$173K
Other$785K$611K$776K$4.39M-$437K$359K$254K$0$0$0
Total Operating Expenses$14.66M$11.89M$11.71M$12.92M$8.34M$7.55M$3.05M$6.73M$4.6M$173K
Operating Income (EBIT)-$12.61M-$10.64M-$10.28M-$12.6M-$8.34M-$5.57M-$2.86M-$5.83M-$4.6M-$173K
Operating Margin-299.1%-348.7%-330.5%-1002.1%--281.4%-1513.7%---
Interest Expense$11K$61K$167K$224K$8K$1.09M$458K$665K$454K$0
Interest Income$110K$102K$85K$10K$14K$14K$97$188$0$151K
Other Income (Expense)$139K$40K$92K$1.93M$3K-$1.49M-$336K-$1.56M-$453K-$139K
Income Before Tax (EBT)-$12.47M-$10.6M-$10.19M-$10.66M-$8.33M-$7.06M-$3.19M-$7.39M-$5.06M-$312K
Income Tax Expense$0$0$0$0$0$0$0-$58K-$36K$0
Net Income-$12.43M-$10.57M-$10.16M-$10.63M-$8.31M-$7.04M-$3.16M-$7.34M-$5.02M-$340K
Net Income Margin-294.9%-346.2%-326.4%-845.9%--355.3%-1676.2%---
Supplementary Data
EPS-8.44-20.00-63.80-105.80-113.30-162.20-89.20-210.10-146.00-9.90
Diluted EPS-8.44-20.00-63.80-105.80-113.30-162.20-89.20-210.10-146.00-9.90
Weighted Average OS1.47M527,364318,500200,90073,32652,07470,92060,39660,39660,396
EBITDA-$11.29M-$9.21M-$8.81M-$9.47M-$8.33M$0$0-$896K$467$16K
EBITDA Margin-267.9%-301.7%-283.1%-753.8%------
Balance Sheet
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Assets
Current Assets
Cash and Cash Equivalents$3.99M$1.02M$6.3M$1.54M$8.24M$12.57M$427K$198K$418K$56K
Short-Term Investments$0$0$0$0$47K$0$0$0$0$0
Cash and Short-Term Investments$3.99M$1.02M$6.3M$1.54M$8.28M$12.57M$427K$198K$418K$56K
Accounts Receivable$848K$1.6M$978K$833K$1.53M$2.1M$20K$95K$36K$0
Inventory$419K$635K$778K$980K$0$0$0$1.98M$2.03M$0
Other Current Assets$1.84M$395K$111K$34K$937K$3.21M$0$0$2M$611K
Total Current Assets$7.1M$4.14M$8.53M$3.86M$10.87M$18.21M$476K$2.33M$2.5M$667K
Long-Term Assets
Property, Plant & Equipment Net$2.05M$321K$873K$1.24M$391K$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0
Intangible Assets$2.8M$3.79M$4.37M$5.26M$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$136K$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$1.09M$3.65M$1.86M$1.98M$1.98M$611K
Total Long-Term Assets$4.84M$4.11M$5.24M$6.49M$1.48M$3.65M$2M$1.98M$1.98M$611K
Other Assets$0$0$0$0$0$0$0-$1.98M-$1.98M-$611K
Total Assets$11.94M$8.25M$13.78M$10.35M$12.35M$21.86M$2.48M$2.33M$2.5M$667K
Liabilities
Current Liabilities
Accounts Payable$712K$897K$602K$1.2M$716K$1.36M$484K$850K$167K$339K
Short-Term Debt$147K$197K$790K$577K$0$0$5.13M$5.13M$4.84M$3.53M
Current Income Tax Payable$0$85K$50K$0$0$0$0$0$0$0
Current Unearned Revenue$0$2.17M$2.49M$2.34M$0$0$0$0$0$0
Other Current Liabilities$4.07M$535K$332K$1.19M$2.84M$2.1M$1.83M$50K$466K$2.71M
Total Current Liabilities$4.93M$5.35M$5.45M$5.88M$4.66M$3.68M$7.69M$6.31M$5.56M$6.58M
Long-Term Liabilities
Long-Term Debt$1.67M$0$0$759K$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$50K$85K$64K-$331K$1.14M$3.17M$0$0$0$0
Total Long-Term Liabilities$1.72M$85K$145K$784K$1.14M$3.17M$0$0$5.01M$3.87M
Other Liabilities$0$0$0$0$0$0$0$0-$5.01M-$3.87M
Total Liabilities$6.65M$5.44M$5.6M$6.67M$5.81M$6.85M$7.69M$6.31M$5.56M$6.58M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$13K$24K$15.03M$8.72M$0
Common Stock$29K$73K$35K$23K$7K$136K$86K$1.95M$0$0
Retained Earnings-$74.96M-$62.53M-$51.96M-$41.81M-$31.18M-$22.87M-$15.83M-$12.67M-$5.33M-$312K
Comprehensive Income & Other-$546K-$328K-$713K-$575K-$788K-$661K-$364K-$217K$571K$3K
Other Stockholders' Equity$80.45M$65.46M$60.26M$45.58M$37.79M$37.79M$10.56M$6.1M$957K-$5.6M
Total Equity$5.51M$3M$8.33M$3.8M$6.62M$15.06M-$5.19M-$4.62M-$4.38M-$5.91M
Minority Interest-$220K-$182K-$146K-$112K-$79K-$51K-$28K$638K$1.31M$0
Total Liabilities and Equity$12.16M$8.43M$13.93M$10.47M$12.43M$21.91M$2.5M$1.69M$1.18M$667K
Supplementary Data
Total Debt$1.82M$282K$1.15M$1.92M$0$0$5.13M$5.13M$4.84M$3.53M
Net Debt-$2.17M-$738K-$5.16M$378K-$8.24M-$12.57M$4.71M$4.93M$4.42M$3.48M
Cash Flow Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Operating Activities
Net Income-$12.47M-$10.6M-$10.19M-$10.66M-$8.33M-$7.06M-$3.19M-$7.39M-$5.06M-$312K
Depreciation & Amortization$1.16M$1.21M$1.21M$967K$0$5.21M$2.6M$5.83M$4.6M$189K
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$195K$238K$230K$260K$0$0$0$1.95M$0$0
Changes in Working Capital:
  Accounts Receivable-$326K-$2.86M-$14K$592K$2.5M-$1.03M$118K$0$0$0
  Inventory$217K$142K$202K-$345K$0$0$0$0$0$0
  Accounts Payable-$685K$0-$633K$85K$243K-$973K$2.41M-$133K-$328K$65K
  Other Working Capital-$431K$2M-$258K-$252K-$305K-$2.94M$99K-$133K-$328K$0
Total Working Capital Change-$1.23M-$721K-$702K$79K$2.44M-$4.94M$2.63M-$133K-$328K$65K
Other Non-Cash Items$408K$197K-$122K$1.98M$2.54M-$4.51M-$2.54M-$5.83M-$4.6M-$186K
Net Cash from Operating-$11.93M-$9.68M-$9.57M-$7.38M-$3.36M-$11.3M-$499K-$5.58M-$5.38M-$244K
Investing Activities
Capital Expenditures-$126K-$232K-$221K-$505K-$380K$0$0$0$0$0
Acquisitions$0$0$0-$189K$0$0-$14K$0$0$0
Purchases of Investments$0$0$0$0-$500K$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$40K$0$0$0$0$0$0$0$0$0
Net Cash from Investing-$86K-$232K-$221K-$694K-$880K$0-$14K$0$0$0
Financing Activities
Debt Repaid----------$3.85M
Common Stock Issuance$14.98M$4.59M$12.9M$2.55M$0$21.6M$0$5.32M$8.02M-$169K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$8K$1.66M-$1.34M$0-$1.49M-$116K$5.32M$3.75M-$3.38M
Net Cash from Financing$14.98M$4.6M$14.56M$1.44M$0$23.4M$734K$5.32M$5.18M$300K
Forex Effect$1K$27K-$707-$65K-$97K$40K$8K$38K$568K$3K
Net Change in Cash$2.97M-$5.28M$4.77M-$6.7M-$4.34M$12.15M$229K-$220K$362K$59K
Supplementary Data
Operating Cash Flow-$11.93M-$9.68M-$9.57M-$7.38M-$3.36M-$11.3M-$499K-$5.58M-$5.38M-$244K
Capital Expenditure-$126K-$232K-$221K-$505K-$380K-$3$0$0$0$0
Free Cash Flow-$12.05M-$9.91M-$9.79M-$7.88M-$3.74M-$11.3M-$499K-$5.58M-$5.38M-$244K
Cash at Beginning$1.02M$6.3M$1.54M$8.24M$12.57M$427K$198K$418K$56K-$3K
Cash at End$3.99M$1.02M$6.3M$1.54M$8.24M$12.57M$427K$198K$418K$56K